Company
Jafron Biomedical Co.,Ltd.
Headquarters: Zhuhai, China
Employees: 2,280
Market Cap
CN¥25.96 Billion
CNY as of Jan. 1, 2023
US$3.76 Billion
Jafron Biomedical Co.,Ltd. Categories
China
languages
Healthcare
languages
Medical Devices
China Healthcare
China Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
Abbott
|
$191.43 B |
Medtronic
|
$103.38 B |
|
Stryker Corporation
|
$92.52 B |
|
Boston Scientific Corporation
|
$65.90 B |
|
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
|
$56.23 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China.
Stocks & Indices
Jafron Biomedical Co.,Ltd. has the following listings and related stock indices.
Stock: SZSE: 300529